Results 191 to 200 of about 1,207,182 (342)
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha +4 more
wiley +1 more source
Vertical Jump and Isometric Strength in Professional Female Basketball Players: Starter vs. Non-Starter Comparison. [PDF]
Nieto-Acevedo R +5 more
europepmc +1 more source
The acute effects of repeated sprints on inter-limb asymmetries during unilateral jumping [PDF]
Chris Bishop +5 more
openalex
Frailty Exacerbates Disability in Progressive Multiple Sclerosis
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks +10 more
wiley +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Reviewer #1 (Public Review): Individual recognition in a jumping spider (Phidippus regius)
Christoph D Dahl, Yaling Cheng
openalex +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
An Exploratory Analysis of Countermovement Jump Variables Between Higher and Lower Performers on the LESS and Y-Balance Tests. [PDF]
Pavlenco C, Talpey S, Gardner EC.
europepmc +1 more source

